Quick Answer
TANDEM DIABETES CARE INC reported Total Assets of $881.11 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed a decrease of -8.9% in Total Assets from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $142.39 million | Q2 2014: $130.02 million | Q3 2014: $116.56 million | Q1 2015: $155.13 million | Q2 2015: $141.33 million | Q3 2015: $128.52 million | Q1 2016: $120.64 million | Q2 2016: $109.19 million | Q3 2016: $90.33 million | Q1 2017: $112.71 million | Q2 2017: $98.54 million | Q3 2017: $87.98 million | Q1 2018: $144.70 million | Q2 2018: $157.99 million | Q3 2018: $181.61 million | Q1 2019: $214.70 million | Q2 2019: $255.08 million | Q3 2019: $292.65 million | Q1 2020: $343.33 million | Q2 2020: $616.24 million | Q3 2020: $672.99 million | Q1 2021: $754.27 million | Q2 2021: $795.25 million | Q3 2021: $850.28 million | Q1 2022: $1.02 billion | Q2 2022: $1.04 billion | Q3 2022: $1.05 billion | Q1 2023: $954.15 million | Q2 2023: $946.68 million | Q3 2023: $939.91 million | Q1 2024: $941.05 million | Q2 2024: $937.50 million | Q3 2024: $957.73 million | Q1 2025: $922.14 million | Q2 2025: $875.74 million | Q3 2025: $874.65 million.
- Over the full 13 years of available data (2013 to 2025), TANDEM DIABETES CARE INC's Total Assets has grown by 443.2%.
- Historical annual values: Fiscal year 2025: $881.11 million | Fiscal year 2024: $967.66 million | Fiscal year 2023: $952.66 million | Fiscal year 2022: $1.05 billion | Fiscal year 2021: $905.14 million | Fiscal year 2020: $716.42 million | Fiscal year 2019: $326.11 million | Fiscal year 2018: $206.29 million | Fiscal year 2017: $95.35 million | Fiscal year 2016: $112.39 million | Fiscal year 2015: $124.73 million | Fiscal year 2014: $106.46 million | Fiscal year 2013: $162.22 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: